Crizalk 250 mg (Crizotinib) Capsule

1
CRIZALK 250MG

• Blueberrypharma, a fully licensed and regulated
  pharmacy medicine, takes all precautions to
  strictly abide by the laws and regulations set
  forth in the dispensing of prescription
  medications.
• Website

2
Crizalk 250mg is used for the therapy of patients
with metastatic non-small cell lung cancer

• Crizalk 250mg belongs to type of tyrosine kinase
  inhibitor. Kinases are enzymes which are included
  in many functions, involving cell development and
  reproduction
• Before using Crizalk in some condition, consult
  with doctor
• Hepatotoxicity
• Interstitial lung disease/pneumonitis
• QT interval prolongation
• Bradycardia 
• Severe visual loss
• Embryo-fetal toxicity

3
PRODUCT DETAILS

• Brand Crizalk
• Ingredients Crizotinib
• Strength 250mg
• Manufactured Pfizer Ltd

4
DOSAGE

• DRUG DRUG INTERACTION
• Combination with strong or moderate CYP3A4
  inhibitors will increase Crizalk plasma
  concentration
• Crizalk interaction with strong CYP3A inducers
  will decrease crizalk plasma concentration
• Interaction with CYP3A substrates will increase
  plasma concentration of CYP3A substrates
• Do not use combination with bradycardia causing
  drugs

5
SIDE EFFECTS

• Infection increased Breathlessness Eyesight
  changes Bowel changes Feeling sick Swelling
  of hands and feets Decreased appetite
  Fatigue Liver changes Skin rash bradycardia

6
CONTACT

• Phone
• 91-97890 77748
• Email
• info_at_blueberrypharma.com
• Address
• New No. 3, Old No. 19,
• Cauvery Nagar 2nd Street,
• Kodungaiyur,
• Chennai - 600 118.
• Website